The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

BACKGROUND: Vascular disease is associated with increased risk of dementia. Vascular health worsens with age. We investigated the relationship between self-reported vascular disease and brain pathology. METHODS: Brain donations to the population-based MRC Cognitive Function and Ageing Study (n=456,...

Full description

Bibliographic Details
Main Authors:	Richardson, K, Stephan, B, Ince, P, Brayne, C, Matthews, F, Esiri, M
Format:	Journal article
Language:	English
Published:	2012

Similar Items

New pathological findings from the MRC-cognitive function and ageing study (CFAS) neuropathology cohort
by: Ince, P, et al.
Published: (2006)

An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
by: Chatfield Mark, et al.
Published: (2006-07-01)

Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)
by: Paykel Eugene S, et al.
Published: (2007-07-01)

The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort
by: Ishihara Lianna, et al.
Published: (2006-08-01)

Transient neurological symptoms in the older population: report of a prospective cohort study-the Medical Research Council Cognitive Function and Ageing Study (CFAS)
by: Mavaddat, N, et al.
Published: (2013)

Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
by: Kingston, A, et al.
Published: (2017)

Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation
by: Matthews Fiona E, et al.
Published: (2004-04-01)

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
by: Skrobot, O, et al.
Published: (2016)

Neuropathology of a community sample of elderly demented and non-demented people
by: Ince, P, et al.
Published: (2000)

Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches
by: S. B. Wharton, et al.
Published: (2019-12-01)

Neuropathological assessment of the lesions of significance in vascular dementia.
by: Esiri, M, et al.
Published: (1997)

White matter lesions (WMI) in a population based autopsy cohort of ageing brains: Frequency, severity, clinical associations including cognitive decline and relation to vascular risk factors
by: Fernando, MS, et al.
Published: (2004)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
by: Webb, D, et al.
Published: (1999)

Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study
by: Laura D. Gamble, et al.
Published: (2022-05-01)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
by: Hann, I, et al.
Published: (1998)

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.
by: Moorman, A, et al.
Published: (2003)

Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review
by: Brayne Carol, et al.
Published: (2006-01-01)

Association between subcortical vascular disease on CT and neuropathological findings.
by: Rossi, R, et al.
Published: (2004)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
by: Chessels, J, et al.
Published: (1997)

Using the Medical Research Council (MRC) Effectiveness Research Framework to evaluate Computer Assisted Therapy (CAT) for 'Dual Diagnosis'- Breaking Free Online
by: Sarah Nell Elison, et al.
Published: (2014-11-01)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1994)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1997)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
by: Hann, I, et al.
Published: (2000)

Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study
by: Chatfield M, et al.
Published: (2009-06-01)

The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study.
by: Fiona Matthews, et al.
Published: (2005-08-01)

Pro: Can neuropathology really confirm the exact diagnosis?
by: Esiri, M
Published: (2010)

Common age‐related neuropathologies and yearly variability in cognition
by: Lei Yu, et al.
Published: (2019-11-01)

Configuration for a grounded lossy impedance simulator employing CC-CFAs and grounded passive elements
by: Jain Manoj Kumar, et al.
Published: (2023-01-01)

A neuropathologic feature of brain aging: multi-lumen vascular profiles
by: Eseosa T. Ighodaro, et al.
Published: (2023-08-01)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
by: Vora, A, et al.
Published: (2008)

Interim report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage.
by: Macnaughton, M, et al.
Published: (1988)

Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service
by: Hart Sam, et al.
Published: (2006-10-01)

Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients
by: Shih-Lung Cheng, et al.
Published: (2019-01-01)

Neuropathology through the ages
by: Kurt A. Jellinger
Published: (2020-08-01)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
by: Wheeler, K, et al.
Published: (1998)

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
by: Vora, A, et al.
Published: (2008)

THE CANCER FUNCTIONAL ASSESSMENT SET (CFAS) CLOSELY REFLECTS THE PHYSICAL- FUNCTION QUALITY OF LIFE OF CHEMOTHERAPY AND RADIOTHERAPY PATIENTS
by: Kenta Kawamura, et al.
Published: (2023-01-01)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
by: J. M. Short, et al.
Published: (2023-09-01)

Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
by: Sarah C. Conner, et al.
Published: (2019-12-01)